28th Oct 2025 13:53
Genedrive PLC - Manchester-based point-of-care pharmacogenetic testing company - Announces that its exclusive distribution partner in Saudi Arabia, iDeal iDea for Medical Equipment Technology, has signed a memorandum of understanding with Saudi Arabia's Ministry of Health. The MoU scope is to pilot Genedrive's MT-RNR1 ID Kit for potential national implementation under an initiative called "Generations Hear." Genedrive Chief Executive Officer Gino Miele says: "We are delighted with the signing of this MOU, which builds further on our commercial traction in Saudi Arabia and aligns perfectly to the long-term Saudi health goals. We are grateful to our valued partners at iDeal iDea for their support and look forward to progressing through pilot phase with the goal of implementation at national level."
Current stock price: 0.67 pence each, up 49% on Tuesday afternoon in London
12-month change: down 70%
By Tom Budszus, Alliance News slot editor
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Related Shares:
Genedrive